The promoting effects of key genes CLIC1 and NAP1L1 on HCC proliferation, migration, and invasion behaviors were verified through in vitro experiments, providing important experimental evidence for the development of ICD-related therapeutic targets. Here, NAP1L1 is linked to hepatocellular carcinoma.